MCIA
RXST icon

Mountain Capital Investment Advisors’s RxSight RXST Stock Holding History

Mountain Capital Investment Advisors’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,779
Closed -$267K – 68
2024
Q4 		$267K Buy
8,779
+320
+4% +$14.4K 0.06% 45
2024
Q3 		$385K Buy
8,459
+459
+6% +$23.5K 0.08% 35
2024
Q2 		$389K Hold
8,000
– – 0.1% 28
2024
Q1 		$441K Sell
8,000
-4,100
-34% -$201K 0.12% 22
2023
Q4 		$548K Hold
12,100
– – 0.19% 42
2023
Q3 		$306K Hold
12,100
– – 0.11% 45
2023
Q2 		$371K Hold
12,100
– – 0.14% 55
2023
Q1 		$216K Hold
12,100
– – 0.1% 61
2022
Q4 		$162K Hold
12,100
– – 0.07% 72
2022
Q3 		$134K Hold
12,100
– – 0.07% 84
2022
Q2 		$174K Buy
+12,100
New +$160K 0.09% 74

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Mountain Capital Investment Advisors's RXST Position: Q1 2025 in Review

Mountain Capital Investment Advisors sold out of RxSight (RXST) in Q1 2025, closing a stake of 8,779 shares — an estimated $267K sold.

Mountain Capital Investment Advisors first reported a position in RXST in Q2 2022 and held it in 11 quarters. The position peaked at $548K in Q4 2023. 192 funds tracked by Wall St. Rank hold RXST as of Q1 2025.

  • Mountain Capital Investment Advisors reported no remaining RxSight position as of Q1 2025 after selling out during the quarter.
  • Mountain Capital Investment Advisors sold 8,779 RxSight shares in Q1 2025, an estimated $267K.
  • Mountain Capital Investment Advisors first reported a position in RxSight in Q2 2022 and held it in 11 quarters.
  • Mountain Capital Investment Advisors's RxSight position peaked at $548K in Q4 2023.
  • 192 funds tracked by Wall St. Rank held RxSight as of Q1 2025.

Based on Mountain Capital Investment Advisors's 13F filing for Q1 2025, filed 28 Apr 2025.